This inventor holds 2 USPTO granted patents. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Oravax-Merieux Co.. Active years: 1999-2000.
Location History:
- Lausanne, CH (1999)
- Romammotier, CH (2000)
Company Filing History:
1 out of 1,328 
1 out of 4 Years Active: 1999-2000
Title: Andre Blum: Innovator in Vaccine Development
Introduction
Andre Blum is a notable inventor based in Romammotier, Switzerland. He has made significant contributions to the field of immunology, particularly in the development of vaccines against Helicobacter infections. With a total of 2 patents, his work has the potential to impact public health positively.
Latest Patents
Among his latest patents is an innovative vaccine composition derived from Helicobacter pylori. This urease-based vaccine aims to elicit a protective immune response in mammalian hosts against Helicobacter infection. The method involves administering an immunogenically effective amount of Helicobacter urease or its subunits as an antigen. These advancements in vaccine technology are crucial for combating Helicobacter-related diseases.
Career Highlights
Throughout his career, Andre Blum has worked with esteemed organizations such as the Max Planck Society for the Advancement of Science and Oravax-Merieux Co. His experience in these institutions has allowed him to refine his research and contribute to groundbreaking developments in vaccine science.
Collaborations
Andre has collaborated with notable colleagues, including Rainer Haas and Irene Corthesy-Theulaz. Their combined expertise has fostered a productive environment for innovation and research in the field of immunology.
Conclusion
In summary, Andre Blum's contributions to vaccine development, particularly against Helicobacter infections, highlight his role as a significant inventor in the field. His patents and collaborations reflect a commitment to advancing public health through innovative solutions.